
Global Active Implantable Medical Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
-
8247
-
Jan 2022
-
160
-
PDF
-
-
“Global Active Implantable Medical Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global active implantable medical devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global active implantable medical devices market report has been segmented on the basis of product and region.
Introduction:
Any active medical device which is intended to be totally or partially introduced by surgically or medical procedure into the human body, and which is intended to remain after the carrying out procedure is called as active implantable medical devices.
Market Dynamics:
Key factors expected to drive growth of the global active implantable medical devices market is increasing prevalence of chronic diseases such as cardiovascular, neurological diseases, etc. In addition, increasing healthcare expenditure, growing elderly population, rising governments funding for R&D activates and technological advancement, are among some other factors expected to drive growth of the target market. Furthermore, favorable reimbursement policies, increasing accessibility for healthcare facilities, rapid development of the healthcare sector, changing lifestyle, increasing awareness regarding cardiac diseases, are some other factors expected to drive growth revenue of the target market over the forecasted period. However, stringent regulatory approval and high cost of implants are factors expected to hamper growth of the global active implantable medical devices market to a certain extent in the forecast period.
Trends:
Major players are collaborating with other players in order to develop technologically advance product in order to cater the demand for minimal invasive treatment procedures. In addition, government of several countries are funding for carrying out R&D activities and trails for reducing the global burden of chronic diseases. For instance, in 2017, Cochlear Ltd. collaborated with Apple, Inc. in order to offer cochlear implants with iPhone connectivity, which was launched in July 2017.
Regional Analysis:
The market in North America is expected to dominate the global active implantable medical devices market. This is primarily attributed to rising prevalence of cardiovascular and chronic pain diseases in countries in the region. In 2017, according to the Centers for Disease Control and Prevention (CDC) around 2.7 to 6.1 Mn people in the US are suffering from atrial fibrillation, which is the most common type of heart arrhythmia. In contrast, the market in Asia Pacific is expected to be an emerging market for the global active implantable medical devices market, and is expected to register highest CAGR in during the forecasted period. This is primarily attributed to rising healthcare spending, growing healthcare infrastructural, increasing demand for advanced technologies in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register high growth revenue in the global active implantable medical devices market over the forecast period.
GLOBAL ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION:
Segmentation by product:
- Implantable Cardioverter Defibrillators
- Transvenous Implantable Cardioverter Defibrillators
- Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
- Dual-Chamber Implantable Cardioverter Defibrillators
- Single-Chamber Implantable Cardioverter Defibrillators
- Subcutaneous Implantable Cardioverter Defibrillators
- Transvenous Implantable Cardioverter Defibrillators
- Ventricular Assist Devices
- Implantable Heart Monitors/Insertable Loop Recorders
- Neurostimulators
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Gastric Electrical Stimulators
- Implantable Hearing Devices
- Active Hearing Implants
- Non-active/Passive Hearing Implants
Segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - Implantable Cardioverter Defibrillators
-
- Medtronic plc.
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- LivaNova PLC
- Cochlear Limited
- Sonova Holding AG
- William Demant Holding A/S
- Nurotron Biotechnology Co. Ltd.
- MED-EL
-
Request for TOC
-
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!